170k spike in NPL.SI (Niks Professional Ltd, SES) AH 02 Feb 2026: Liquidity

A 170,000 share volume spike pushed attention to the NPL.SI stock after hours on 02 Feb 2026. The rise in activity is notable because average daily volume is 3,200, giving a relative volume of 53.13x. At the session close Niks Professional Ltd (NPL.SI) traded at SGD 0.23 on the SES. We assess what the spike means for liquidity, short-term price action and where analysts and our models place the stock

NPL.SI stock: immediate market action and volume context

The defining fact is the 170,000 share print versus an avg volume 3,200. That volume created a large intraday liquidity window on the SES and suggests one or a few large participants moved the tape. One clear metric: relVolume 53.13 indicates the session was not retail-only and can magnify intraday swings. The price closed at SGD 0.23, unchanged on the print, implying the spike was concentrated in a narrow price band and may reflect block trades or portfolio rebalancing.

NPL.SI stock: fundamentals and valuation snapshot

Niks Professional Ltd reports a market cap of SGD 29.90M with shares outstanding 130,000,000. Recent reported EPS is SGD 0.01 and the quoted PE sits at 23.00 based on the last trade. Key balance-sheet metrics show a current ratio 5.31 and debtToEquity 0.06, indicating low leverage and a strong short-term liquidity cushion. Price/Book is 1.53 and price/sales about 2.65, placing NPL.SI roughly in line with small-cap healthcare peers on SES but below larger healthcare multiples.

NPL.SI stock: technical and liquidity indicators after the spike

Technicals show muted trend signals: RSI 47.15 and ADX 16.63 indicate no dominant trend. On volume metrics the OBV 209,000 rose with the spike, but Bollinger bands remain tight (upper 0.23 middle 0.23 lower 0.22) consistent with a narrow price range during the surge. The spike increases short-term liquidity and lowers transaction costs for larger orders, which can attract directional traders if follow-through occurs in subsequent sessions.

NPL.SI stock: growth, cash flow and dividend profile

Operationally, trailing metrics show revenuePerShare 0.09 and freeCashFlowPerShare 0.02. Return on equity is 9.76% and operating cash coverage metrics are healthy: interestCoverage 33.05. The company paid dividendPerShare 0.24 historically, but dividend growth has been uneven. Given modest top-line growth (FY revenue growth 3.10%), NPL.SI’s cash generation supports dividends and clinic expansion, but investors should watch margin stability and retail product demand.

Meyka AI rating and NPL.SI stock forecast analysis

Meyka AI rates NPL.SI with a score out of 100: 63.14 (Grade B, HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a quarterly target SGD 0.25 and yearly target SGD 0.33 versus the current price SGD 0.23, implying a one-year upside of about 43.48%. Forecasts are model-based projections and not guarantees. Analysts should weigh the model outlook against trading liquidity, clinic demand trends, and macro conditions in Singapore’s healthcare sector.

NPL.SI stock: risks and short-term opportunities after the volume spike

Short-term opportunity: increased liquidity can let larger buyers build positions with less slippage and may attract momentum traders if follow-through volume appears. Primary risks include low market cap sensitivity to single trades and concentration risk; a few trades can move price materially. Operational risks include slower-than-expected clinic traffic and retail skincare demand changes. Monitor next sessions for sustained volume above 10,000 shares and any company announcements.

Final Thoughts

Key takeaways: the after-hours 170,000 volume surge in NPL.SI stock on 02 Feb 2026 dramatically exceeded the stock’s avg volume 3,200 and temporarily raised liquidity. Fundamentals show low leverage, a current ratio 5.31, EPS 0.01, and a PE near 23.00, which combined suggest a small-cap healthcare with cash cover but modest earnings. Meyka AI’s model projects a yearly target SGD 0.33, implying an upside near 43.48% from SGD 0.23, but that projection is not a guarantee. For traders the immediate watch is follow-through volume and whether the spike marks accumulation or a one-off block. For longer-term investors, weigh valuation, clinic demand trends, and earnings cadence. We use real-time signals in our AI-powered market analysis platform to monitor NPL.SI stock and will flag any news-driven changes to price or liquidity

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.